As reported, S100A9 modulates macrophage inflammation in AMI and regulates microglial inflammation in depression (Ma et al., 2017; Marinković et al., 2019), yet the evidence of it is not quite adequate in post-AMI depression. Here, S100A9 is linked to major depressive disorder.